Literature DB >> 1412124

The pulmonary physician and critical care. 3. Pharmacotherapy in lung injury.

M Messent1, M J Griffiths.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1412124      PMCID： PMC463931          DOI： 10.1136/thx.47.8.651

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  70 in total

1.  Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value.

Authors:  D E Hammerschmidt; L J Weaver; L D Hudson; P R Craddock; H S Jacob
Journal:  Lancet       Date:  1980-05-03       Impact factor: 79.321

2.  High-dose corticosteroids in patients with the adult respiratory distress syndrome.

Authors:  G R Bernard; J M Luce; C L Sprung; J E Rinaldo; R M Tate; W J Sibbald; K Kariman; S Higgins; R Bradley; C A Metz
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

3.  Adult respiratory distress syndrome. Prognosis after onset.

Authors:  A A Fowler; R F Hamman; G O Zerbe; K N Benson; T M Hyers
Journal:  Am Rev Respir Dis       Date:  1985-09

4.  Acute respiratory distress in adults.

Authors:  D G Ashbaugh; D B Bigelow; T L Petty; B E Levine
Journal:  Lancet       Date:  1967-08-12       Impact factor: 79.321

5.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

6.  Actions of lipoxygenase metabolites in isolated rat lungs.

Authors:  N F Voelkel; K R Stenmark; J T Reeves; M M Mathias; R C Murphy
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-09

7.  Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. A prospective trial.

Authors:  J W Holcroft; M J Vassar; C J Weber
Journal:  Ann Surg       Date:  1986-04       Impact factor: 12.969

8.  Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution.

Authors:  Y Hamasaki; M Mojarad; T Saga; H H Tai; S I Said
Journal:  Am Rev Respir Dis       Date:  1984-05

9.  Causes of mortality in patients with the adult respiratory distress syndrome.

Authors:  A B Montgomery; M A Stager; C J Carrico; L D Hudson
Journal:  Am Rev Respir Dis       Date:  1985-09

10.  Experimental and clinical results in shock lung treatment with vitamin E.

Authors:  H R Wolf; H W Seeger
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.